Force Health Surveillance in the NATO Does Not Meet the Needs of Its Users: A Structured Evaluation of EpiNATO-2

INTRODUCTION

Disease and non-battle injuries (DNBIs) cause substantial losses among military personnel. NATO has monitored DNBIs among its personnel since 1996 using multiple versions of a tool now called EpiNATO-2, but the surveillance system has never been systematically evaluated. Following a request from NATO to the CDC, the objective of this study was to assess surveillance system attributes of EpiNATO-2 using CDC's updated guidelines for evaluating public health surveillance systems.

MATERIALS AND METHODS

Between June and October 2022, a literature review and key informant interviews were conducted to assess the following attributes: usefulness, simplicity, flexibility, data quality, acceptability, sensitivity, positive predictive value, representativeness, timeliness, stability, informatics system quality, informatics service quality, and informatics interoperability. Key informant interviews were conducted in Kosovo, Germany, and remotely with EpiNATO-2 users spanning three levels: clinical and data entry personnel (tactical level); regional medical and public health officers (operational level); and senior commanders and other governmental entities (strategic level).

RESULTS

Fourteen EpiNATO-2 users participated in interviews, representing 3 of the 5 major NATO missions, 3 partner entities, and 7 nationalities. All users (100%) reported that the system did not meet their needs, with most users noting the following challenges: lack of clearly defined system objectives; poor data quality due to ambiguous case definitions and frequently unsubmitted reports (37% missing during January to June 2022); long delay between the occurrence of health events and the availability of corresponding data (≥2 weeks); and an antiquated and inflexible data management system. Overall, performance was deemed unsatisfactory on 11 of the 13 attributes.

CONCLUSIONS

This multinational sample of EpiNATO-2 users at all military levels reported that the system is currently not useful with respect to its stated objectives. Opportunities exist to improve the performance and usefulness of EpiNATO-2: improve case definitions, modernize data infrastructure, and regularly evaluate the surveillance system.

Les actions du service de santé des armées face à la crise COVID-19: sur mer et au-delà des mers, toujours au service des hommes !

« Nous sommes en guerre ! » a déclaré le président Emmanuel Macron lors d’un discours à la nation le 16 mars 2020. Dans le cadre de cette résilience nationale, le service de santé des armées (SSA) s’est engagé dans la lutte contre le COVID-19. Cette revue générale a pour objectif de décrire et de détailler les actions que le SSA a mené dans le cadre de la lutte nationale contre la pandémie de COVID-19 en France, ainsi qu’à l’étranger. Des experts de chaque domaine ont rapporté les actions majeures menées par le SSA lors de la pandémie de COVID-19. En quelques semaines seulement, le SSA a développé des capacités médicales ad hoc pour soutenir les autorités sanitaires nationales. Il a également mis en œuvre des capacités d’évacuations médicales collectives par voie aérienne et maritime. Un hôpital militaire de campagne dédié aux soins intensifs a également été déployé en soutien de l’hôpital civil à Mulhouse. Plus tard, des modules militaires de réanimation ont aidé des centres hospitaliers débordés par l’afflux de malades COVID-19 en Guadeloupe, en Martinique, en Guyane, à Mayotte et en Nouvelle-Calédonie. Une cellule de crise COVID-19 a permis de coordonner les actions des forces armées françaises dans le cadre de la lutte contre la pandémie. Le centre d’épidémiologie et de santé publique des armées a fourni toutes les informations nécessaires pour guider les processus de prises de décisions. Les centres médicaux des armées ont organisé les soins primaires pour les patients militaires, avec un large recours à la télémédecine. Les services de secours de la Brigade des sapeurs-pompiers de Paris et du Bataillon des marins-pompiers de Marseille ont assuré la prise en charge préhospitalière des patients atteints de COVID-19. Les huit hôpitaux d’instruction militaires français ont coopéré avec les agences régionales de santé pour permettre la prise en charge hospitalière des patients les plus graves, mais aussi créer de novo des centres de vaccination. La chaîne de ravitaillement médical des armées a soutenu tous les déploiements d’unités médicales opérationnelles en France et à l’étranger, faisant face à une pénurie croissante de matériel médical. L’institut de recherche biomédicale des armées a réalisé des diagnostics, s’est engagé dans de multiples projets de recherche, a mis à jour quotidiennement la revue de la littérature scientifique sur le COVID-19 et a fourni des recommandations d’experts sur la biosécurité. Enfin, les étudiants des écoles militaires de santé de Lyon-Bron se sont portés volontaires pour participer à la lutte contre la pandémie de COVID-19. En conclusion, dans une crise médicale sans précédent, le SSA a engagé de multiples actions innovantes et adaptatives, toujours en cours, dans la lutte contre le COVID-19. La collaboration entre les systèmes de santé militaires et civils a renforcé l’objectif commun de « sauver le plus grand nombre ».

How do we fight COVID-19? Military medical actions in the war against the COVID-19 pandemic in France

'We are at war', French President Emmanuel Macron said in an address to the nation on 16 March 2020. As part of this national effort, the French Military Medical Service (FMMS) is committed to the fight against COVID-19. This original report aimed to describe and detail actions that the FMMS has carried out in the nationwide fight against the COVID-19 pandemic in France, as well as overseas. Experts in the field reported major actions conducted by the FMMS during the COVID-19 pandemic in France. In just few weeks, the FMMS developed ad hoc medical capabilities to support national health authorities. It additionally developed adaptive, collective en route care via aeromedical and naval units and deployed a military intensive care field hospital. A COVID-19 crisis cell coordinated the French Armed Forces health management. The French Military Centre for Epidemiology and Public Health provided all information needed to guide the decision-making process. Medical centres of the French Armed Forces organised the primary care for military patients, with the widespread use of telemedicine. The Paris Fire Brigade and the Marseille Navy Fire Battalion emergency departments ensured prehospital management of patients with COVID-19. The eight French military training hospitals cooperated with civilian regional health agencies. The French military medical supply chain supported all military medical treatment facilities in France as well as overseas, coping with a growing shortage of medical equipment. The French Armed Forces Biomedical Research Institute performed diagnostics, engaged in multiple research projects, updated the review of the scientific literature on COVID-19 daily and provided expert recommendations on biosafety. Finally, even students of the French military medical academy volunteered to participate in the fight against the COVID-19 pandemic. In conclusion, in an unprecedented medical crisis, the FMMS engaged multiple innovative and adaptive actions, which are still ongoing, in the fight against COVID-19. The collaboration between military and civilian healthcare systems reinforced the shared objective to achieve the goal of 'saving the greatest number'.